Carl Zeiss Meditec announces CLARUS 700 receives NMPA approval in China (€59.25, 0.00)
Carl Zeiss Meditec downgraded to hold from buy at mwb research (earlier, 11:22 CET) (€62.30, +0.40)
Carl Zeiss Meditec CEO Markus Weber to leave company (€60.40, +0.45)
Carl Zeiss Meditec receives FDA clearance for INTRABEAM 700 (€52.05, -0.90)
StreetAccount Summary - Trading higher/lower: EU mid-morning
Powered by FactSet Research Systems Inc.